Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients
Chouinard, G.; Annable, L.; Ross-Chouinard, A.
Psychopharmacology Bulletin 22(3): 891-896
1986
ISSN/ISBN: 0048-5764 PMID: 2879310 Document Number: 285673
Document emailed within 1 workday
Related Documents
Csernansky, J.G.; Vinogradov, S.; Prosser, E.; Kaplan, J.; Berger, P.A.; Hollister, L.E. 1986: Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis Psychopharmacology Bulletin 22(3): 897-899Staton, R.D.; Brumback, R.A. 1980: Neuroleptic-induced reinnervation sprouting in the central nervous system (a model for the development of tardive dyskinesia and supersensitivity psychosis) Journal of Clinical Psychiatry 41(12 Part 1): 427-428
Jeste, D.V.; Wyatt, R.J. 1981: Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity? Journal of Clinical Psychiatry 42(12): 455-457
Christensen, A.V.; Nielsen, I.M. 1980: Dopaminergic supersensitivity: influence of dopamine agonists and drugs used for the treatment of tardive dyskinesia Advances in Biochemical Psychopharmacology 24: 341-349
Bajulaiye, R.; Addonizio 1992: Clozapine in the treatment of psychosis in an 82-year-old woman with tardive dyskinesia Journal of Clinical Psychopharmacology 12(5): 364-365
Rittmannsberger, H.; Schöny, W. 1986: Prevalence of tardive dyskinesia in long-term hospitalized schizophrenic patients Der Nervenarzt 57(2): 116-118
Karniol, I.G.; Portela, W. 1982: Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study Brazilian Journal of Medical and Biological Research 15(6): 389-394
Spivak, B.; Mester, R.; Abesgaus, J.; Wittenberg, N.; Adlersberg, S.; Gonen, N.; Weizman, A. 1997: Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients Journal of Clinical Psychiatry 58(7): 318-322
Nagao, T.; Ohshimo, T.; Mitsunobu, K.; Sato, M.; Otsuki, S. 1979: Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor Biological Psychiatry 14(3): 509-523
Sato, M. 1986: Acute exacerbation of methamphetamine psychosis and lasting dopaminergic supersensitivity--a clinical survey Psychopharmacology Bulletin 22(3): 751-756
Bourgeois, M. 1977: Tardive Dyskinesia induced by neuroleptics: a survey of 3140 patients in a psychiatric hospital L'Encephale 3(4): 299-320
Huh, L.; Lee, B.Ju. 2015: Efficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report Psychiatria Danubina 27(2): 195-197
Camp, E.W. 1977: Tardive dyskinesia oral facial dyskinesia with moban Diseases of the Nervous System 38(9): 759
Gualtieri, C.T.; Sprague, R.L. 1984: Preventing tardive dyskinesia and preventing tardive dyskinesia litigation Psychopharmacology Bulletin 20(3): 346-348
Granacher, R.P. 1978: The tardive dyskinesia syndrome Journal of the Kentucky Medical Association 76(1): 13-17
Calne, D.B.; Claveria, L.E.; Teychenne, P.F.; Haskayne, L.; Lodge-Patch, I.C. 1974: Pimozide in tardive dyskinesia Transactions of the American Neurological Association 99: 166-170
Gunne, L.M.; Häggström, J.E.; Johansson, P.; Levin, E.D.; Terenius, L. 1988: Neurobiochemical changes in tardive dyskinesia L'Encephale 14(Special Issue): 167-173
Crane, G.E. 1971: More on amantadine in tardive dyskinesia New England Journal of Medicine 285(20): 1150-1151
Wolf, M.E.; DeWolfe, A.S.; Ryan, J.J.; Lips, O.; Mosnaim, A.D. 1985: Vulnerability to tardive dyskinesia Journal of Clinical Psychiatry 46(9): 367-368
Gardos, G.; Sokol, M.; Cole, J.O.; Sniffin, C. 1976: Eye color and tardive dyskinesia Psychopharmacology Bulletin 12(2): 7 8-7 9